Loading clinical trials...
Loading clinical trials...
Feasibility of the LUM Imaging System for Detection of Primary Pancreatic Cancer and Peritoneal Invasion From Primary Pancreatic Cancer During Surgery
Conditions
Interventions
LUM Imaging System
Locations
1
United States
Massachusetts General Hospital
Boston, Massachusetts, United States
Start Date
January 1, 2026
Primary Completion Date
January 1, 2026
Completion Date
January 1, 2026
Last Updated
March 13, 2024
NCT02600949
NCT03050268
NCT06423326
NCT07542041
NCT07283705
NCT07438106
Lead Sponsor
Lumicell, Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions